DSpace at RU >

Browsing by Faculty / Department Cardiology

Full Text	Issue Date	Title	Author(s)
	2011	Anatomical extent of pulmonary vein isolation after cryoballoon ablation for atrial fibrillation: comparison between the 23 and 28 mm balloons	Chierchia, G.B.; Asmundis, C. de; Sorgente, A., et al
	2011	Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo	Meijer, P.; Wouters, C.W.; Oyen, W.J.G., et al
	2007	Anticoagulants in heart disease: current status and perspectives.	Caterina, R. de; Husted, S.; Wallentin, L., et al
	2004	Anticoagulation in cardiac disease : New data - New options - Introduction	Verheugt, F.W.A.; Antman, E.A.
	2007	Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.	Dieker, H.J.; French, J.K.; Joziasse, I.C., et al
	2007	Antiplatelet treatment for coronary heart disease.	Clappers, N.; Brouwer, M.A.; Verheugt, F.W.A.
	2004	Antithrombotic strategies and the impact of coronary reocclusion in ST-elevation myocardial infarction	Brouwer, M.A.
	2006	Antithrombotic therapy in heart failure.	Verheugt, F.W.A.
	2008	Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.	Rubboli, A.; Halperin, J.L.; Juhani Airaksinen, K.E., et al
	2008	Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician.	Rubboli, A.; Verheugt, F.W.A.
	2006	Antitrombotische therapie bij patiënten met hartfalen	Verheugt, F.W.A.
	2005	Antitrombotische therapie na een myocardinfarct : argumenten voor acetylsalicylzuur én cumarinederivaten	Waskowsky, W.M.; Brouwer, A.; Verheugt, F.W.A.
	2005	Antitrombotische therapie rondom percutane coronaire interventie	Verheugt, F.W.A.; Dieker, H.J.; Aengevaeren, W.R.M.
	2005	Aortic root growth in men and women with the Marfan's syndrome.	Meijboom, L.J.; Timmermans, J.; Zwinderman, A.H., et al
	2010	Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.	Lopes, R.D.; Alexander, J.H.; Al-Khatib, S.M., et al
	2011	Apixaban versus warfarin in patients with atrial fibrillation	Granger, C.B.; Alexander, J.H.; McMurray, J.J., et al
	2011	Apixaban with antiplatelet therapy after acute coronary syndrome	Alexander, J.H.; Lopes, R.D.; James, S., et al
	2007	Are there differences in outcome following PCI between patients with STEMI and those with non-STEMI?	Verheugt, F.W.A.
	2004	Association of aspirin use with vitamin B12 deficiency (results of the BACH study).	Oijen, M.G.H. van; Laheij, R.J.F.; Peters, W.H.M., et al
	2011	Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study	Balci, A.; Sollie, K.M.; Mulder, B.J., et al